Healthcare provider profile · identity verified

Harrell Clark Royer, MD

Family Practice · BREVARD, NC · NPI 1831170901

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	453	158
Losartan Potassium	Losartan Potassium	337	116
Levothyroxine Sodium	Levothyroxine Sodium	251	88
Rosuvastatin Calcium	Rosuvastatin Calcium	248	94
Amlodipine Besylate	Amlodipine Besylate	243	102
Lisinopril	Lisinopril	228	80
Omeprazole	Omeprazole	208	78
Gabapentin	Gabapentin	166	64
Hydrochlorothiazide	Hydrochlorothiazide	165	63
Metoprolol Succinate	Metoprolol Succinate	164	55
Eliquis	Apixaban	155	39
Sertraline Hcl	Sertraline Hcl	149	53
Metformin Hcl Er	Metformin Hcl	147	51
Trazodone Hcl	Trazodone Hcl	137	45
Tamsulosin Hcl	Tamsulosin Hcl	136	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	36
Allopurinol	Allopurinol	109	38
Pantoprazole Sodium	Pantoprazole Sodium	106	37
Simvastatin	Simvastatin	100	32
Metformin Hcl	Metformin Hcl	88	38
Alendronate Sodium	Alendronate Sodium	81	36
Famotidine	Famotidine	79	28
Alprazolam	Alprazolam	78	19
Duloxetine Hcl	Duloxetine Hcl	78	29
Clonazepam	Clonazepam	75	18
Escitalopram Oxalate	Escitalopram Oxalate	72	26
Potassium Chloride	Potassium Chloride	72	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	32
Albuterol Sulfate Hfa	Albuterol Sulfate	65	22
Metoprolol Tartrate	Metoprolol Tartrate	63	20
Fluticasone Propionate	Fluticasone Propionate	60	27
Furosemide	Furosemide	57	26
Zolpidem Tartrate	Zolpidem Tartrate	54	24
Tramadol Hcl	Tramadol Hcl	53	25
Oxycodone Hcl	Oxycodone Hcl	52	16
Prednisone	Prednisone	48	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Spironolactone	Spironolactone	44	17
Bupropion Xl	Bupropion Hcl	43	11
Citalopram Hbr	Citalopram Hydrobromide	43	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	13
Chlorthalidone	Chlorthalidone	41	14
Ezetimibe	Ezetimibe	41	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	16
Montelukast Sodium	Montelukast Sodium	41	19
Pravastatin Sodium	Pravastatin Sodium	40	17
Esomeprazole Magnesium	Esomeprazole Magnesium	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	15
Lorazepam	Lorazepam	37	14
Meloxicam	Meloxicam	37	18
Jardiance	Empagliflozin	36	15
Carvedilol	Carvedilol	35	16
Doxycycline Hyclate	Doxycycline Hyclate	34	30
Clopidogrel	Clopidogrel Bisulfate	33	14
Diazepam	Diazepam	33	11
Warfarin Sodium	Warfarin Sodium	32	14
Amoxicillin	Amoxicillin	30	26
Finasteride	Finasteride	30	12
Ozempic	Semaglutide	29	11
Temazepam	Temazepam	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Pregabalin	Pregabalin	27	11
Estradiol	Estradiol	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Cephalexin	Cephalexin	22	14
Glimepiride	Glimepiride	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	16
Azithromycin	Azithromycin	20	16
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Triamcinolone Acetonide	Triamcinolone Acetonide	20	15
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Valsartan	Valsartan	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Atenolol	Atenolol	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Klor-Con M20	Potassium Chloride	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Nystatin	Nystatin	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error